SBIR/STTR Research Award

Preclinical Evaluation of a Biofabricated Implant for Rotator Cuff Tendon-Enthesis Regeneration

Award identifier 514fe6efc9db9bd19c27384f1b10f3f4619096dc32ce30a4e4630f5485470bbaAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$223,907

Program and phase

SBIR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Embody, Inc.
Proposal award date
2019-09-19
Contract end date
2020-03-31
UEI
TDARNMFL46M1
Solicitation number
PA18-574
Topic code
NIAMS

Research abstract

Preclinical Evaluation of a Biofabricated Implant for Rotator Cuff Tendon Enthesis Regeneration Project Summary Abstract Rotator cuff injuries are a major clinical problemleading tosurgical rotator cuff repairRCRprocedures performed annually in the U SaloneRe rupture rates following RCR are reported upwards ofwith the current standard of careAddressing the clinical need for improving rotator cuff healingthe goals of this research are to optimize the biomanufacturingpreservation and in vivo performance of a Biologically enhanced Tissue ENgineered DeviceBio TENDfor tendon and tendon to boneenthesisregenerationSupported by multiple patentsBio TEND isa wellcharacterizedanisotropicresorbable collagen microfibrous graft electrospun from a benign solventengineered for high void to promote rapid cellular ingrowth and remodelingandbiomanufactured with clinical grade stem cells primed for tendon and fibrocartilage formation to promote enthesis regenerationOur hypothesis is that Bio TEND grafts will accelerate the production of newhost generateddenseregularly oriented tendon like tissue and enthesis integration in a RCR modelWe will accomplish two specific aims necessary for progressing through FDA approval and to commercializationAimEstablish Optimal Bio TEND Biomanufacturing and Preservation StrategiesAimAssess Bio TEND in a Chronic Rat RCR ModelSuccessful completion of our SBIR Phase I work will yield biomanufacturing of a therapeutic for RCRincluding scale uppreservation and performance studiesThis work will lead to pivotal testing in large animals and Mechanism of Action studies in SBIR Phase IIand human clinical trials in Phase IIIResults of these SBIR studies will provide the data required for FDA submission and to successfully market the productThis project brings together investigators with the necessary complementary expertise in the translation of medical devices and cellular therapiesDrFrancisEmbodyand tendon biologybiomechanics and animal models for RCRDrSoslowskyPennworking together with world class surgeons to develop this critical therapeutic Preclinical Evaluation of a Biofabricated Implant for Rotator Cuff TendonEnthesis Regeneration Project Narrative This work will develop an advanced biomanufactured graft to significantly improve rotator cuff healing for thepatients with surgical rotator cuff repair annually in the U Swhich is critically needed in light of the upwards ofre rupture rates reportedThe goals of this research are to optimize the biomanufacturingpreservation and performance of a Biologically enhanced Tissue ENgineered DeviceBio TENDfor tendon and tendon to boneenthesisregenerationand to evaluate putative mechanisms of actionMOAand therapeutic potential in vivoOur hypothesis is that Bio TEND grafts will accelerate the production of newhostgenerateddenseregularly oriented tendon like tissue and enthesis integration in a rotator cuff repair model

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

9 SBIR/STTR records share this UEI (2019–2022). Reported award amounts total $7,757,313. Reported amounts are not federal obligations.

Phases: Phase II, Phase I, Phase II – Direct to Phase II

Agencies: Department of Defense, Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.